Krónikus limfoid leukémia (CLL): vizsgálatok itt: Hongkong

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Where

  Hong Kong

  Életkor

  18 év and over

  People

  1200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136559 · EU 2022-501697-19-01
• 2. fázisNot yet taking people in Hongkong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Életkor

  18 év and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408